Showing results (21-30 of 42) with videos related to
Sort By:
Pageof 5
The Journal of Infectious Diseases|July 28, 2018
Antiviral Activity, Safety, and Pharmacokinetics of AL-794, a Novel Oral Influenza Endonuclease Inhibitor: Results of an Influenza Human Challenge StudyJeysen Yogaratnam, Jennifer Rito, Thomas N Kakuda, et al.Antiviral Research|December 15, 2006
Novel CCR5 monoclonal antibodies with potent and broad-spectrum anti-HIV activitiesChanghua Ji, Michael Brandt, Marianna Dioszegi, et al.Antimicrobial Agents and Chemotherapy|February 9, 2011
Development of tetravalent, bispecific CCR5 antibodies with antiviral activity against CCR5 monoclonal antibody-resistant HIV-1 strainsJürgen Schanzer, Andreas Jekle, Junichi Nezu, et al.Antiviral Research|September 8, 2020
Evaluation of SARS-CoV-2 3C-like protease inhibitors using self-assembled monolayer desorption ionization mass spectrometryZachary A Gurard-Levin, Cheng Liu, Andreas Jekle, et al.Bioorganic & Medicinal Chemistry Letters|September 4, 2013
Sulfonyl-polyol N,N-dichloroamines with rapid, broad-spectrum antimicrobial activityTimothy P Shiau, Eddy Low, Bum Kim, et al.Journal of Medicinal Chemistry|April 28, 2016
Synthesis and Anti-Influenza Activity of Pyridine, Pyridazine, and Pyrimidine C-Nucleosides as Favipiravir (T-705) AnaloguesGuangyi Wang, Jinqiao Wan, Yujian Hu, et al.Journal of Virology|September 27, 2023
Novel non-HAP class A HBV capsid assembly modulators have distinct <i>in vitro</i> and <i>in vivo</i> profilesHannah Vanrusselt, Dieudonné Buh Kum, Valerio Taverniti, et al.Plos One|December 11, 2020
Regulation of gene transcription by thyroid hormone receptor β agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH)Xuan G Luong, Sarah K Stevens, Andreas Jekle, et al.Hepatology (Baltimore, Md.)|April 27, 2023
Class A capsid assembly modulator RG7907 clears HBV-infected hepatocytes through core-dependent hepatocyte death and proliferationDieudonné Buh Kum, Hannah Vanrusselt, Abel Acosta Sanchez, et al.Bioorganic & Medicinal Chemistry Letters|August 14, 2009
Spiropiperidine CCR5 antagonistsDavid M Rotstein, Stephen D Gabriel, Ferenc Makra, et al.Pageof 5